Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
Antiarrhtytmic medication classification (AMC) was proposed by V. Williams and modified by D. Harrison in the time when antiarrhythmic activity of cardiac receptor and ion channel activators was less known, and their effects on bilipid sarcolemma layer was not regarded as a method for bioelectrical...
Saved in:
| Main Authors: | T. N. Lipnitsky, V. A. Kozlovsky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2007-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Theoretical basis and search for new methods of cardiac arrhythmias' pathogenetic therapy
by: V. M. Moroz, et al.
Published: (2005-12-01) -
THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01) -
Pediatric antiarrhythmics and toxicity: A clinical review
by: Alexandra T. Geanacopoulos, et al.
Published: (2024-02-01) -
Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01) -
Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)